Literature DB >> 16094518

The effect of peritoneal rest in combination therapy of peritoneal dialysis and hemodialysis: using the cultured human peritoneal mesothelial cell model.

Tadashi Tomo1, Eiji Okabe, Kazuhiro Matsuyama, Tomohiko Iwashita, Keiko Yufu, Masaru Nasu.   

Abstract

The effects of peritoneal rest for 24 h during peritoneal dialysis and hemodialysis combination therapy were investigated using cultured human peritoneal mesothelial cell (HPMC) models. Cell activity was investigated by 3-[4,5-dimethylthiazol-2-yl]-2, 5-diphenylterazolium bromide (MTT) assay after exposing HPMCs to peritoneal dialysis fluids (PDFs) with different pH levels. The following PDFs (50 microl/well) were used for exposure durations of 30 or 240 min: acidic heat-sterilized PDFs (L-H PDF, pH 5.5) and neutral heat-sterilized PDFs (N-H PDF, pH 6.7). Control wells were exposed to M-199 Hanks medium containing 20% fetal bovine serum (FBS) for 30 or 240 min. Supernatants were then aspirated from each well and M-199 culture medium containing 20% FBS (50 microl) was added to each well to rest HPMCs for 24 h before investigation of MTT activity. The activity of HPMCs exposed to L-H PDF for 240 min decreased to approximately 20% and 15% when compared with controls (glucose concentrations of 1.36% and 3.86%, respectively; P < 0.01 versus control, Tukey-Kramer test), and to approximately 60% and 40% after exposure to N-H PDF for 240 min (glucose: 1.36% and 3.86%; P < 0.01). The activity of HPMCs exposed to L-H PDF for 240 min followed by rest was approximately 20% and 4% when compared with controls (glucose: 1.36% and 3.86%; P < 0.01) and was 93% and 96% when compared with controls after exposure to N-H PDF for 240 min followed by rest (glucose: 1.36% and 3.86%). These findings suggest that rest for 24 h after exposure to N-H PDF improves the activity of HPMCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16094518     DOI: 10.1007/s10047-005-0290-3

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  20 in total

1.  Two-stage isolation procedure for obtaining homogenous populations of microvascular endothelial and mesothelial cells from human omentum.

Authors:  N Chung-Welch; W F Patton; D Shepro; R P Cambria
Journal:  Microvasc Res       Date:  1997-09       Impact factor: 3.514

2.  Isolation, culture and characterization of human peritoneal mesothelial cells.

Authors:  E Stylianou; L A Jenner; M Davies; G A Coles; J D Williams
Journal:  Kidney Int       Date:  1990-06       Impact factor: 10.612

3.  Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids.

Authors:  C G Schalkwijk; N Posthuma; H J ten Brink; P M ter Wee; T Teerlink
Journal:  Perit Dial Int       Date:  1999 Jul-Aug       Impact factor: 1.756

4.  Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH.

Authors:  T Liberek; N Topley; A Jörres; M M Petersen; G A Coles; G M Gahl; J D Williams
Journal:  Nephron       Date:  1993       Impact factor: 2.847

5.  AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression.

Authors:  Eric Boulanger; Marie-Paule Wautier; Jean-Luc Wautier; Bernadette Boval; Yves Panis; Nicolas Wernert; Pierre-Marie Danze; Philippe Dequiedt
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

6.  Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.

Authors:  T Miyata; K Horie; Y Ueda; Y Fujita; Y Izuhara; H Hirano; K Uchida; A Saito; C van Ypersele de Strihou; K Kurokawa
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

7.  Combined peritoneal dialysis and hemodialysis: our experience compared to others.

Authors:  Mamta Agarwal; Patricia Clinard; John M Burkart
Journal:  Perit Dial Int       Date:  2003 Mar-Apr       Impact factor: 1.756

8.  In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function.

Authors:  N Topley; D Kaur; M M Petersen; A Jörres; J D Williams; D Faict; C J Holmes
Journal:  J Am Soc Nephrol       Date:  1996-02       Impact factor: 10.121

Review 9.  Review of combination of peritoneal dialysis and hemodialysis as a modality of treatment for end-stage renal disease.

Authors:  H Fukui; S Hara; Y Hashimoto; T Horiuchi; M Ikezoe; N Itami; M Kawabe; H Kawanishi; H Kimura; Y Nakamoto; M Nakayama; M Ono; K Ota; T Shinoda; T Suga; T Ueda; M Fujishima; T Maeba; A Yamashita; Y Yoshino; S Watanabe
Journal:  Ther Apher Dial       Date:  2004-02       Impact factor: 1.762

10.  Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products.

Authors:  K N Lai; J C K Leung; L Y Y Chan; F F K Li; S C W Tang; M F Lam; K C Tse; T P Yip; T M Chan; A Wieslander; H Vlassara
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

View more
  2 in total

1.  Clinical application of computer-aided diagnostic system for harmonious introduction of complementary dialysis therapy.

Authors:  Abdullah Al Mamun; Hiroyuki Hamada; Tomokazu Karino; Shinji Namoto; Akihiro C Yamashita; Makoto Ishizaki; Masahiro Okamoto
Journal:  Open Biomed Eng J       Date:  2008-04-01

Review 2.  APD or CAPD: one glove does not fit all.

Authors:  Athanasios Roumeliotis; Stefanos Roumeliotis; Konstantinos Leivaditis; Marios Salmas; Theodoros Eleftheriadis; Vassilios Liakopoulos
Journal:  Int Urol Nephrol       Date:  2020-10-13       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.